"10.1371_journal.pmed.1000239","plos medicine","2010-02-23T00:00:00Z","Marcel Wolbers; Abdel Babiker; Caroline Sabin; Jim Young; Maria Dorrucci; Geneviève Chêne; Cristina Mussini; Kholoud Porter; Heiner C Bucher; on behalf of the CASCADE Collaboration","Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Program, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Medical Research Council Clinical Trials Unit, London, United Kingdom; University College London Medical School, London, United Kingdom; Istituto Superiore di Sanità, Rome, Italy; Université Bordeaux II, Bordeaux, France; University of Modena and Reggio Emilia and Azienda Policlinico, Modena, Italy","ICMJE criteria for authorship read and met: MW AB CS JY MD GC CM KP HCB. Agree with the manuscript's results and conclusions: MW AB CS JY MD GC CM KP HCB. Designed the experiments/the study: MW AB KP HCB. Analyzed the data: MW. Collected data/did experiments for the study: CS MD GC KP HCB. Enrolled patients: MD. Wrote the first draft of the paper: MW. Contributed to the writing of the paper: AB CS JY MD GC CM KP HCB. MW had full access to all data in the study and had final responsibility for the decision to submit this report for publication. Secured funding for the study: KP. Obtained funding for the project: HCB.","HCB received travel grants, honoraria, and unrestricted research grants from various pharmaceutical companies including, GlaxoSmithKline, Bristol-Myers-Squibb, Gilead, Roche, Abbott, Tibotec, and Boehringer-Ingelheim. The research of MW, JY, and HCB is supported by unrestricted grants from santésuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. The Medical Research Council, Clinical Trials HIV Group, led by AB, received donated drugs and/or financial support for substudies from the following pharmaceutical companies: Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, Gilead, Tibotec, Roche, GlaxoSmithKline, Indevus, Merck, Novartis, Sanofi Pasteur, and Virco. KP also received honorarium from Tibotec. CS has received funding for research, teaching, and consultancy from several pharmaceutical companies (GlaxoSmithKline, Gilead Sciences, Bristol-Myers Squibb, and Tibotec) over the last few years. CM received travel grants and honoraria from: GlaxoSmithKline, Bristol-Myers-Squibb, Gilead, Roche, Abbott, Tibotec, and Boehringer-Ingelheim. The research of CM is supported by Istituto Superiore di Sanità.","2010","02","Marcel Wolbers","MW",10,TRUE,NA,NA,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
